A novel modified peptide derived from membrane-proximal external region of human immunodeficiency virus type 1 envelope significantly enhances retrovirus infection

Journal of Peptide Science

Volumn 20, Issue 1, 2014, Pages 46-54

  Zhang, Lishuang ^a   Jiang, Chunlai ^a   Zhang, Huayan ^a   Gong, Xin ^a   Yang, Lan ^a   Miao, Liang ^a   Shi, Yuhua ^a   Zhang, Yan ^a   Kong, Wei ^a   Zhang, Chuntao ^b   Shan, Yaming ^a  

^a JILIN UNIVERSITY   (China)

^b NATIONAL INSTITUTES FOR FOOD AND DRUG CONTROL   (China)

Author keywords

aromatic; cationic; HIV 1 infection enhancement; MPER based peptides; retroviral transduction

Indexed keywords

AMYLOID; GLYCOPROTEIN GP 41; P13 PEPTIDE; P16 PEPTIDE; PEPTIDE DERIVATIVE; THIOFLAVINE; UNCLASSIFIED DRUG; VIRUS ENVELOPE PROTEIN;

ARTICLE; BINDING ASSAY; CYTOTOXICITY; GENE TRANSFER; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; NONHUMAN; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; RETROVIRUS INFECTION; ZETA POTENTIAL;

AROMATIC; CATIONIC; HIV-1 INFECTION ENHANCEMENT; MPER-BASED PEPTIDES; RETROVIRAL TRANSDUCTION;

AMINO ACID SEQUENCE; AMYLOID; CELL LINE; HIV ENVELOPE PROTEIN GP41; HIV-1; HUMANS; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; PROTEIN STRUCTURE, TERTIARY; TRANSDUCTION, GENETIC; VIRUS ATTACHMENT;

EID: 84890910865     PISSN: 10752617     EISSN: 10991387     Source Type: Journal    
DOI: 10.1002/psc.2587     Document Type: Article

References (37)

1. Mátrai J, Chuah MK, VandenDriessche T,. Recent advances in lentiviral vector development and applications. Mol. Ther. 2010; 18: 477-490.
2. Bailey CA, Miller DK, Lenard J,. Effects of DEAE-dextran on infection and hemolysis by VSV. Evidence that nonspecific electrostatic interactions mediate effective binding of VSV to cells. Virology 1984; 133: 111-118.
3. Davis HE, Morgan JR, Yarmush ML,. Polybrene increases retrovirus gene transfer efficiency by enhancing receptor-independent virus adsorption on target cell membranes. Biophys. Chem. 2002; 97: 159-172.
4. Cornetta K, Anderson WF,. Protamine sulfate as an effective alternative to polybrene in retroviral-mediated gene-transfer: implications for human gene therapy. J. Virol. Methods 1989; 23: 187-194.
5. Münch J, Rücker E, Ständker L, Adermann K, Goffinet C, Schindler M, Wildum S, Chinnadurai R, Rajan D, Specht A, Giménez-Gallego G, Sánchez PC, Fowler DM, Koulov A, Kelly JW, Mothes W, Grivel JC, Margolis L, Keppler OT, Forssmann WG, Kirchhoff F,. Semen-derived amyloid fibrils drastically enhance HIV infection. Cell 2007; 131: 1059-1071.
6. Roan NR, Müller JA, Liu H, Chu S, Arnold F, Stürzel CM, Walther P, Dong M, Witkowska HE, Kirchhoff F, Münch J, Greene WC,. Peptides released by physiological cleavage of semen coagulum proteins form amyloids that enhance HIV infection. Cell Host Microbe 2011; 10: 541-550.
7. Wojtowicz WM, Farzan M, Joyal JL, Carter K, Babcock GJ, Israel DI, Sodroski J, Mirzabekov T,. Stimulation of enveloped virus infection by beta-amyloid fibrils. J. Biol. Chem. 2002; 277: 35019-35024.
8. Yolamanova M, Meier C, Shaytan AK, Vas V, Bertoncini CW, Arnold F, Zirafi O, Usmani SM, Müller JA, Sauter D, Goffinet C, Palesch D, Walther P, Roan NR, Geiger H, Lunov O, Simmet T, Bohne J, Schrezenmeier H, Schwarz K, Ständker L, Forssmann W-G, Salvatella X, Khalatur PG, Khokhlov AR, Knowles TPJ, Weil T, Kirchhoff F, Münch J,. Peptide nanofibrils boost retroviral gene transfer and provide a rapid means for concentrating viruses. Nat. Nanotechnol. 2013; 8: 130-136.
9. Wolk DA, Zhang Z, Boudhar S, Clark CM, Pontecorvo MJ, Arnold SE,. Amyloid imaging in Alzheimer's disease: comparison of florbetapir and Pittsburgh compound-B positron emission tomography. J. Neurol. Neurosurg. Psychiatry 2012; 83: 923-926.
10. Temussi PA, Masino L, Pastore A,. From Alzheimer to Huntington: why is a structural understanding so difficult? Embo J. 2003; 22: 355-361.
11. Westermark P,. Aspects on human amyloid forms and their fibril polypeptides. FEBS J. 2005; 272: 5942-5949.
12. Atwood CS, Martins RN, Smith MA, Perry G,. Senile plaque composition and posttranslational modification of amyloid-beta peptide and associated proteins. Peptides 2002; 23: 1343-1350.
13. Wallis C, Melnick JL,. Mechanism of enhancement of virus plaques by cationic polymers. J. Virol. 1968; 2: 267-274.
14. Roan NR, Münch J, Arhel N, Mothes W, Neidleman J, Kobayashi A, Smith-McCune K, Kirchhoff F, Greene WC,. The cationic properties of SEVI underlie its ability to enhance human immunodeficiency virus infection. J. Virol. 2009; 83: 73-80.
15. Easterhoff D, DiMaio JT, Doran TM, Dewhurst S, Nilsson BL,. Enhancement of HIV-1 infectivity by simple, self-assembling modular peptides. Biophys. J. 2011; 100: 1325-1334.
16. Wurm M, Schambach A, Lindemann D, Hanenberg H, Ständker L, Forssmann WG, Blasczyk R, Horn PA,. The influence of semen-derived enhancer of virus infection on the efficiency of retroviral gene transfer. J. Gene Med. 2010; 12: 137-146.
17. Wurm M, Gross B, Sgodda M, Ständker L, Müller T, Forssmann WG, Horn PA, Blasczyk R, Cantz T,. Improved lentiviral gene transfer into human embryonic stem cells grown in co-culture with murine feeder and stroma cells. Biol. Chem. 2011; 392: 887-895.
18. Cai L, Gochin M, Liu K,. Biochemistry and biophysics of HIV-1 gp41-membrane interactions and implications for HIV-1 envelope protein mediated viral-cell fusion and fusion inhibitor design. Curr. Top. Med. Chem. 2011; 11: 2959-2984.
19. Huarte N, Lorizate M, Pérez-Payá E, Nieva JL,. Membrane-transferring regions of gp41 as targets for HIV-1 fusion inhibition and viral neutralization. Curr. Top. Med. Chem. 2011; 11: 2985-2996.
20. Muñoz-Barroso I, Salzwedel K, Hunter E, Blumenthal R,. Role of the membrane-proximal domain in the initial stages of human immunodeficiency virus type 1 envelope glycoprotein-mediated membrane fusion. J. Virol. 1999; 73: 6089-6092.
21. Montero M, van Houten NE, Wang X, Scott JK,. The membrane-proximal external region of the human immunodeficiency virus type 1 envelope: dominant site of antibody neutralization and target for vaccine design. Microbiol. Mol. Biol. Rev. 2008; 72: 54-84, table of contents.
22. Montero M, Gulzar N, Klaric KA, Donald JE, Lepik C, Wu S, Tsai S, Julien JP, Hessell AJ, Wang S, Lu S, Burton DR, Pai EF, Degrado WF, Scott JK,. Neutralizing epitopes in the membrane-proximal external region of HIV-1 gp41 are influenced by the transmembrane domain and the plasma membrane. J. Virol. 2012; 86: 2930-2941.
23. Morris L, Chen X, Alam M, Tomaras G, Zhang R, Marshall DJ, Chen B, Parks R, Foulger A, Jaeger F, Donathan M, Bilska M, Gray ES, Abdool Karim SS, Kepler TB, Whitesides J, Montefiori D, Moody MA, Liao HX, Haynes BF,. Isolation of a human anti-HIV gp41 membrane proximal region neutralizing antibody by antigen-specific single B cell sorting. PLoS One 2011; 6: 30.
24. Salzwedel K, West JT, Hunter E,. A conserved tryptophan-rich motif in the membrane-proximal region of the human immunodeficiency virus type 1 gp41 ectodomain is important for Env-mediated fusion and virus infectivity. J. Virol. 1999; 73: 2469-2480.
25. Suárez T, Gallaher WR, Agirre A, Goñi FM, Nieva JL,. Membrane interface-interacting sequences within the ectodomain of the human immunodeficiency virus type 1 envelope glycoprotein: putative role during viral fusion. J. Virol. 2000; 74: 8038-8047.
26. Vishwanathan SA, Hunter E,. Importance of the membrane-perturbing properties of the membrane-proximal external region of human immunodeficiency virus type 1 gp41 to viral fusion. J. Virol. 2008; 82: 5118-5126.
27. Hübner W, Chen P, Del Portillo A, Liu Y, Gordon RE, Chen BK,. Sequence of human immunodeficiency virus type 1 (HIV-1) Gag localization and oligomerization monitored with live confocal imaging of a replication-competent, fluorescently tagged HIV-1. J. Virol. 2007; 81: 12596-12607.
28. Loewen N, Barraza R, Whitwam T, Saenz DT, Kemler I, Poeschla EM,. FIV vectors. Methods Mol. Biol. 2003; 229: 251-271.
29. Toyama BH, Weissman JS,. Amyloid structure: conformational diversity and consequences. Annu. Rev. Biochem. 2011; 80: 557-585.
30. Biancalana M, Koide S,. Molecular mechanism of thioflavin-T binding to amyloid fibrils. BBA-Proteins Proteom. 2010; 7: 22.
31. Khurana R, Coleman C, Ionescu-Zanetti C, Carter SA, Krishna V, Grover RK, Roy R, Singh S,. Mechanism of thioflavin T binding to amyloid fibrils. J. Struct. Biol. 2005; 151: 229-238.
32. Green M, Loewenstein PM,. Autonomous functional domains of chemically synthesized human immunodeficiency virus Tat trans-activator protein. Cell 1988; 55: 1179-1188.
33. Lehmusvaara S, Rautsi O, Hakkarainen T, Wahifors J,. Utility of cell-permeable peptides for enhancement of virus-mediated gene transfer to human tumor cells. Biotechniques 2006; 40: 573-574.
34. Makin OS, Atkins E, Sikorski P, Johansson J, Serpell LC,. Molecular basis for amyloid fibril formation and stability. Proc. Natl. Acad. Sci. U. S. A. 2005; 102: 315-320.
35. Senguen FT, Lee NR, Gu X, Ryan DM, Doran TM, Anderson EA, Nilsson BL,. Probing aromatic, hydrophobic, and steric effects on the self-assembly of an amyloid-beta fragment peptide. Mol. Biosyst. 2011; 7: 486-496.
36. Senguen FT, Doran TM, Anderson EA, Nilsson BL,. Clarifying the influence of core amino acid hydrophobicity, secondary structure propensity, and molecular volume on amyloid-beta 16-22 self-assembly. Mol. Biosyst. 2011; 7: 497-510.
37. Braun P, von Heijne G,. The aromatic residues Trp and Phe have different effects on the positioning of a transmembrane helix in the microsomal membrane. Biochemistry 1999; 38: 9778-9782.